Skip to content

Report a Typo or Mistake

Optional

Optional

Optional

Health Canada delays drug-pricing reforms, citing COVID challenges for manufacturers
Verify
push icon
Be the first to read breaking stories. Enable push notifications on your device. Disable anytime.
No thanks